• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

New generators power Gendex resurgence

Article

X-ray and mammography vendor Gendex Medical is returning to theRSNA meeting with a more stable corporate outlook than it hadat last year's show. The company exhibited at the 1994 meetingas a vendor on the auction block after parent Dentsply

X-ray and mammography vendor Gendex Medical is returning to theRSNA meeting with a more stable corporate outlook than it hadat last year's show. The company exhibited at the 1994 meetingas a vendor on the auction block after parent Dentsply Internationalsaid it was planning to sell the Franklin Park, IL, firm (SCAN10/26/94).

Dentsply in June decided to maintain ownership of Gendex andhas withdrawn its bid to divest the company, according to a Gendexspokesperson. Indeed, Dentsply has renewed its commitment to Gendexand has given it the go-ahead to hire 50 new employees in thelast several months, the spokesperson said.

Gendex's RSNA booth will be twice as large as it was last year,according to the company. Among the new products on display isa new line of generators that will mark Gendex's entry into theradiography/fluoroscopy market. Gendex will also feature fournew high-frequency radiography generators.

In mammography, the company will show a new stereotactic biopsydevice for the Mamex mammography system. It can be used for uprightand recumbent procedures.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.